Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr 11;14(4):790.
doi: 10.3390/v14040790.

Elimination of HCV in Russia: Barriers and Perspective

Vasily Isakov  1   2 , Dmitry Nikityuk  1   2
Affiliations
Review

Elimination of HCV in Russia: Barriers and Perspective

Vasily Isakov et al. Viruses. .

Abstract

Hepatitis C virus (HCV) is highly prevalent in Russia, representing the largest pool of hepatitis C patients in Europe. Effective treatment regimens with direct-acting antivirals can achieve HCV cure in all patients; therefore, in 2016 the World Health Organization proposed eliminating hepatitis C as a public health threat by 2030. However, only a small number of countries are on track to meet the WHO's hepatitis C elimination targets by 2030 due to many barriers in healthcare systems. This review focuses on a discussion about the epidemiology of HCV in Russia, the economic burden of HCV-related diseases, and treatment access with particular reference to the barriers for the elimination of HCV.

Keywords: HCV; Russia; elimination program.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Incidence of chronic and acute HCV infection in Russia in 2011–2020 (per 100,000 of population) [6].
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Petruzziello A., Marigliano S., Loquercio G., Cacciapuoti C. Hepatitis C virus (HCV) genotypes distribution: An epidemiological up-date in Europe. Infect. Agents Cancer. 2016;11:53. doi: 10.1186/s13027-016-0099-0. - DOI - PMC - PubMed
    1. Maistat L., Kravchenko N., Reddy A. Hepatitis C in Eastern Europe and Central Asia: A survey of epidemiology, treatment access and civil society activity in eleven countries. Hepatol. Med. Policy. 2017;2:9. doi: 10.1186/s41124-017-0026-z. - DOI - PMC - PubMed
    1. Blach S., Zeuzem S., Manns M., Altraif I., Duberg A.-S., Muljono D.H., Waked I., Alavian S.M., Lee M.-H., Negro F., et al. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study. Lancet Gastroenterol. Hepatol. 2017;2:161–176. doi: 10.1016/S2468-1253(16)30181-9. - DOI - PubMed
    1. Pimenov N.N., Komarova S.V., Tsapkova N.N., Volchkova E.V., Chulanov V.P. Hepatitis C and its outcomes in Russia: Analysis of incidence, prevalence and mortality rates before the start of the programme of infection elimination. Infektsionnye Bolezn. 2018;16:37–45. doi: 10.20953/1729-9225-2018-3-37-45. (In Russian) - DOI
    1. Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor) Sanitary and Epidemiological Surveillance in Russian Federation in 2019: State Report. Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor); Moscow, Russia: 2020. p. 299.

Publication types

MeSH terms

Substances